HRSA-22-032: Supporting Replication (SURE) of Housing Interventions in the Ryan White HIV/AIDS Program – Evaluation Provider
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make one award worth $800,000 in total. Applications closed on February 23, 2022.
From the official notice on Grants.gov, last changed November 22, 2021. Checked November 7, 2026.
- Total funding$800,000
- Expected awards1
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | November 22, 2021 |
|---|---|
| Deadline | February 23, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Eligible applicants include entities eligible for funding under Ryan White HIV/AIDS Program Parts A - D of Title XXVI of the Public Health Service (PHS) Act, including public and nonprofit private entities; state and local governments; academic institutions; local health departments; nonprofit hospitals and outpatient clinics; and community health centers receiving support under Section 330 of the PHS Act. Domestic faith-based and community-based organizations, tribes, and tribal organizations are also eligible to apply.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Special Projects of National Significance (SPNS) Program2 project titled Supporting Replication (SURE) of Housing Interventions in the Ryan White HIV/AIDS Program - Evaluation Provider (EP). The purpose of this project is to support a single organization that serves as an EP and uses an implementation science framework (HAB IS)3 to evaluate housing-related intervention strategies for the following three key populations of people with HIV experiencing unstable housing who often have the highest HIV-related disparities (see Background Section I.2): 1) lesbian, gay, bisexual, transgender, and queer or questioning (LGBTQ+); 2) youth and young adults (ages 13-24); and 3) people who have been justice involved (i.e., people impacted by the justice system). The SURE Housing initiative has two separate, yet coordinated recipients: the EP, which will be funded under this announcement (HRSA-22-032), and a separately funded announcement for an Implementing and Technical Assistance Provider (ITAP) (HRSA-22-031). The companion announcement will issue subawards to up to 10 implementation sites to implement and adapt selected interventions. Throughout this initiative, the EP will work closely with the ITAP, which will provide implementation technical assistance (TA) to the sites. The EP’s evaluation findings will support the ITAP in promoting the communication and dissemination of relevant replication materials for widespread adoption by the broader RWHAP, HIV, and housing communities in need of effective strategies to better serve people with HIV experiencing unstable housing. The EP will develop and implement a multi-site evaluation and provide evaluation-related TA to each of the implementation sites. The multi-site evaluation will include implementation and client outcomes and a cost analysis that are consistent across the implementation sites. Implementation sites may conduct their own local evaluations with support from the EP as needed. Implementation sites will implement and adapt housing-related intervention strategies. Examples may include, but are not limited to, intervention strategies from the RWHAP 2 HRSA Ryan White HIV/AIDS Program Part F: Special Projects of National Significance (SPNS) Program.
Who has won Special Projects of National Significance grants before
From fiscal 2021 to 2025, Special Projects of National Significance (93.928) awarded $104 million across 85 grant awards, an average of $1.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Fenway Community Health Center, Inc. | Massachusetts | 2 | $20.1 million |
| National Alliance of State & Territorial AIDS Directors | District of Columbia | 1 | $13.9 million |
| Jsi Research & Training Institute Inc | Massachusetts | 6 | $13.3 million |
| Corporation for Supportive Housing | New York | 1 | $13.2 million |
| The Regents of the University of California, San Francisco | California | 4 | $6.2 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-22-032 still open?
No. It closed on February 23, 2022.
Who can apply for Supporting Replication (SURE) of Housing Interventions in the Ryan White HIV/AIDS Program – Evaluation Provider?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Supporting Replication (SURE) of Housing Interventions in the Ryan White HIV/AIDS Program – Evaluation Provider?
Closed February 23, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $800,000 in total for one award.
Who has won Special Projects of National Significance grants before?
The largest recipients over five fiscal years were Fenway Community Health Center, Inc., National Alliance of State & Territorial AIDS Directors, Jsi Research & Training Institute Inc. The program made 85 awards worth $104 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)